Pharma & Biotech

Centene Corporation shares are maintaining their upward trajectory, building on recent positive momentum within the healthcare sector. The stock registered...

While many biotechnology stocks continue to face headwinds, Denali Therapeutics is demonstrating surprising strength in recent trading sessions. The company's...

Sarepta Therapeutics witnessed a dramatic trading session as its stock price jumped more than 10%, closing at $21.32 before extending...

After nearly a century as a publicly traded company, Walgreens Boots Alliance has concluded its stock market journey. The landmark...

The pharmaceutical industry faces a fundamental challenge: balancing medical innovation with affordable access to treatments. Gilead Sciences finds itself at...

Eli Lilly & Company is experiencing a remarkable upward trajectory that has captivated market participants. The pharmaceutical giant's equity has...

Shares of Nektar Therapeutics surged to unprecedented heights this week, reaching a new 52-week peak of $61.24 before settling at...

Cellectar Biosciences is attracting significant market attention following the release of encouraging interim data from its CLOVER-2 Phase 1b study....

Ocugen is executing a strategic campaign to position itself at the forefront of gene therapy. The company has announced a...

DexCom, the continuous glucose monitoring specialist, finds itself navigating turbulent market conditions as conflicting signals emerge about the company's near-term...